Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Myocardial scar characteristics by 3D-LGE cannot fully explain different arrhythmic event rates in primary and secondary prevention of sudden cardiac death
Session:
Comunicações Orais - Sessão 08 - Dispositivos em Arritmologia
Speaker:
Ana Rita Bello
Congress:
CPC 2023
Topic:
C. Arrhythmias and Device Therapy
Theme:
09. Device Therapy
Subtheme:
09.6 Device Therapy - Other
Session Type:
Comunicações Orais
FP Number:
---
Authors:
Ana Rita Bello; Rita Amador; Pedro Freitas; Sara Guerreiro; João Abecasis; Daniel Matos; Gustavo Rodrigues; João Carmo; Pedro Galvão Santos; Francisco Moscoso Costa; Salomé Carvalho; Pedro Carmo; Diogo Cavaco; Francisco Morgado; António Ferreira; Pedro Adragão
Abstract
<p style="text-align:justify"><span style="font-family:Verdana,Geneva,sans-serif"><span style="font-size:11pt"><u>Background</u>: There is a noticeable difference in the incidence of ventricular arrythmias among patients receiving defibrillator devices (ICD or CRT-D) for primary vs. secondary prevention of sudden cardiac death (SCD). The underlying reasons for this difference remain to be fully explained. </span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-family:Verdana,Geneva,sans-serif"><span style="font-size:11pt"><u>Purpose</u>: To assess for differences in myocardial scar characteristics between patients who had defibrillator devices implanted in primary vs. secondary prevention scenarios, and their correlation with arrhythmic events.</span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-family:Verdana,Geneva,sans-serif"><span style="font-size:11pt"><u>Methods</u><span style="color:#222222">: In this single center retrospective study, patients who underwent late gadolinium enhancement (LGE) cardiac MRI for clinical purposes before the implantation of an ICD or CRT-D were included. Patients with channelopathies (n=2) or inappropriate imaging quality (n=7) were excluded. We used ADAS software to perform myocardial scar characterization in 3D-LGE datasets in all but 16 patients, in which 2D datasets were used. The primary endpoint was a composite of appropriate ICD therapy (appropriate shock or ATP), sustained ventricular tachycardia or SCD.</span></span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-family:Verdana,Geneva,sans-serif"><span style="font-size:11pt"><u><span style="color:#222222">Results</span></u><span style="color:#222222">: A total of 116 patients (mean age 66±14 years, 81% male) were included, 40 (35%) with devices implanted in secondary prevention. During a median follow-up of 28 months (IQR 16-24), 23 events were identified (18 appropriate ICD therapy, 9 shocks and 9 ATP; 2 SCD; 3 sustained VT), 7 of which (30.4%) in the primary prevention group, and 16 (69.6%) in the secondary prevention group. The event rate was significantly higher in the secondary prevention setting (</span>15.0 events per 100 persons-year [95% CI 7.7 – 22.4]<span style="color:#222222"> vs. </span>4.1 events per 100 persons-year [95% CI 1.1 – 7.1]; p < 0.001).</span></span></p> <p style="text-align:justify"><span style="font-family:Verdana,Geneva,sans-serif"><span style="font-size:11pt">Despite a higher LVEF in the secondary prevention group (<span style="color:#222222">41 ± 14% vs. 30 ± 13%; p-value < 0.001), </span>no statistically significant differences were found regarding scar tissue characteristics, namely scar and borderzone (BZ) mass, total channel mass, largest channel mass, number of channels and scar heterogeneity <span style="color:#222222">(BZ mass / scar mass ratio) – Image.</span></span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-family:Verdana,Geneva,sans-serif"><span style="font-size:11pt"><span style="background-color:white"><u><span style="color:#222222">Conclusion</span></u><span style="color:#222222">: </span></span></span></span></p> <p style="text-align:justify"><span style="font-family:Verdana,Geneva,sans-serif"><span style="font-size:11pt"><span style="background-color:white"><span style="color:#222222">Despite the higher event rate in patients receiving defibrillator devices in secondary vs. prevention, no differences in myocardial scar characteristics were found between both groups. These findings suggest that arrhythmic risk is unlikely to be explained solely by the anatomical substrate, and support a greater role for the interplay between substrate and transient triggers. </span></span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site